01 / 12
Enquirer Consulting Group / Prepared for Germaine Laboratories, Inc.
July 2026

Credibility is not the gap.
Active outreach is.

Back in June you told us the budget was not there yet. This shows what a proven outbound engine for Germaine Laboratories could look like when that conversation reopens.
DesignBuildRunHand over
BUILDRUNOWN
Enquirer AI is the outbound engine of Enquirer Consulting Group
What we see

A strong product base, waiting for inbound

01
New distributor and partner interest appears to start with an inquiry form.
02
Your diagnostic products serve medical, drug testing, food and beverage, and veterinary markets.
03
The company has deep manufacturing credibility, while its visible digital footprint remains light.
This is our read from the outside, to pressure-test together on a call, not a verdict.
Prepared for Germaine Laboratories, Inc.
Where this goes

Turn credibility into conversations

Today
.
New relationships depend on prospects finding Germaine Laboratories first.
.
A lean sales team covers several distinct markets at once.
In the first weeks and months
+
A focused list of distributor and buyer accounts worth reaching.
+
Relevant outreach built around the right product and market.
+
A working outbound unit that Germaine Laboratories owns after handover.
Enquirer Consulting Group
How the engagement works

Build. Run. Own.

01 / BUILD

Build

We design, staff and stand up the complete unit. The named-account data, the messaging, the outbound engine, the automation and the reporting.

02 / RUN

Run

We run it in market for a fixed four months and prove it on real booked meetings, not slides. First conversations land early.

03 / OWN

Own

We hand over the playbook, the tooling, the dashboards and a trained operator. You own the engine.

One contractor, a network of specialists. One point of contact, and you never manage a stack of tools or freelancers.
We build it, run it in market, then hand you the keys
What we build for Germaine Laboratories, Inc.

What we would build for Germaine

Named accounts

A clear list of distributors and buyers across the markets you serve.

Market-specific outreach

Messages that match the medical, drug testing, food and beverage, or veterinary conversation.

A handover-ready engine

The process, outreach, and meeting flow built to become your team's asset.

When the budget discussion reopens, this gives you a defined engine to bring into it, not an open-ended marketing commitment.
Enquirer Consulting Group
The engine, in plain terms

Every message, written for one real person.

01

Target

We would reach the distributor and buyer accounts that fit Germaine Laboratories' diagnostic products across medical, drug testing, food and beverage, and veterinary markets.

02

Personalize

AI reads each profile and writes a unique message. No templates.

03

Hand off warm

A positive reply pings you and your operator with the prospect and a way to reach them.

04

You take it from there

You take pre-qualified conversations. The engine handles everything before it.

Research-led and human-reviewed. Every message is on-brand, and most of the volume runs on capacity we operate, not only your account.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Why this fits now

Build the outbound motion around what already works

01

Real credibility

Your FDA-registered, ISO 13485 certified product base gives the outreach something substantive to lead with.

02

Focused support

A complete outbound unit helps a small commercial team cover more ground without losing focus.

03

Owned at the end

The engine is built, proven on real meetings, then handed over for Germaine Laboratories to run.

Enquirer Consulting Group
Proof, in the field

We have run this exact engine inside medical.

Tim Rath
Chief Operating Officer, Innovative Radiology
Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
4 mo
A fixed build in market, then the system is yours to keep.
10+
Booked conversations on strong campaigns, in medical, from cold.
Innovative Radiology is a real medical client we ran this engine for. The figures come from strong campaigns and are not a promise of your numbers. We would agree your targets up front and prove against them.
Why ECG

You own it at the end. That is the difference.

+
Without building an outbound team from scratch.
+
Without a permanent agency on retainer forever.
+
Without a stack of tools and freelancers to manage.
+
Without lock-in. You own the engine, including the operator who runs it.
A freelancer sends emails. An agency rents you reps. A consultancy hands you a slide deck. We design the engine, staff it, run it, prove it on real meetings, then hand you the keys.
Enquirer Consulting Group
How we start

Stand up fast. Prove it. Then scale.

Stand up

Build

The named-account data, the messaging, the engine and the dashboard. Day-one capacity from warmed assets and managed seats.

Prove

The test

Run against the KPIs we agree up front. First meetings on the calendar early.

Scale

Ramp

Once the numbers hold, ramp the seats and breadth to the volume you want.

Own

Hand over

Playbook, tooling, dashboards and a trained operator. The engine is yours.

Onboarding sets the targeting and the voice first, so the outreach lands warmer every week.
Enquirer Consulting Group
Next step

Let's see if the mechanism fits.

  1. Dan and Tina have a short call on Germaine Laboratories' distributor and buyer priorities.
  2. Tina sanity-checks the named-account list and the markets it should cover first.
  3. We decide whether there is a fit, or leave it there.
Reply with two or three times that suit and we will work around you, or grab a slot at calendly.com/enquirer/review.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Enquirer Consulting Group

We build it, run it in market, then hand you the keys.

Dan Reeves   /   dan@enquirerconsulting.com   /   calendly.com/enquirer/review
More about us at enquirerconsulting.com
Enquirer AI is the outbound engine of Enquirer Consulting Group. Prepared for Germaine Laboratories, Inc..